The slip
PARKINSON RECEIPTno. 14558
29 Oct 2026, 23:14 UTCdopamine neurons, braak
predictionSLC25A28 in dopamine neurons tracks Braak Lewy-body stage
registeredcea4c5bdb34dc9f4
discovery+0.20 p=0.597 n=9
replication-0.37 p=0.331 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.20, p 0.597)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT7cebcf84d1b9a940e79da422…
follows 3bd3460dd579…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14558: SLC25A28 in dopamine neurons, braak
- power
- full sample -0.17 (p 0.509, n 18), 95% CI -0.59 to +0.33. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.09 (p 0.715, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.23 (p 0.369, n 18). could be the mix.
- skeptic
- leave-one-out range -0.34 to -0.05, sign flips 0; without severely affected donors -0.17 (p 0.509, n 18). fragile.
- cell type
- strongest in astrocytes: -0.69 (p 0.0017, n 18) vs -0.17 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SLC25A28 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SLC25A28 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.07 p 0.790 (needs p < 1.6e-4)